Citizens Bancorp Stock (OTC:CBTN), Trade Ideas

Citizens Bancorp Investment Inc is a commercial bank. The company offers services such as Online and Mobile Banking; Overdraft Privilege; Business Services; Mortgages; Agriculture and others.

CITIZENS BNCRP INVT INC A by Citizens Bancorp Investment, Inc.

Citizens Bancorp Investment Inc

Xpeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) Vice Chairman and Co-President Brian Gu expressed his skepticism about the immediate future of <a href="https://www.benzinga.com/news/24/04/38376273/maybe-elon-musk-hints-driverless-teslas-may-debut-in-this-us-state-but-bugs-will-take-few-months-to">self-driving taxis</a> as a lucrative business.
What Happened: Gu, speaking at the Beijing auto show, said that the commercial viability of robotaxis is at least five years away, <a href="https://www.cnbc.com/2024/04/25/xpengs-gu-says-robotaxis-wont-be-a-real-business-for-at-least-five-years.html">reported</a> CNBC on Thursday. This timeline is notably longer than what Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk has suggested. Tesla is actively developing AI software for a robotaxi network.
&#8220;Right now it&#8217;s not something that we are considering when we are launching and planning the sales,&#8221; said Gu. Xpeng, a China-based electric car startup, has made driver-assist software a key selling point.
&#8220;To have a real, full-fledged commercial operation. I think it's more than 5 years away.&#8221;
Despite this, Gu acknowledged the interest in showcasing technology and achieving milestones in China, where companies like Baidu Inc. and Pony.ai have been authorized to charge for fully driverless taxis in certain areas.
See Also: <a href="https://www.benzinga.com/markets/equities/24/04/38395098/tesla-unveils-timeline-for-electric-semi-truck-production-first-units-to-external-customers-by-2?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Unveils Timeline For Scaling Up Electric Semi-Truck Production, First Units From New Factory To &#8216;Ex</a>
Why It Matters: Musk has been a vocal advocate for the potential of robotaxis, despite challenges such as recent <a href="https://www.benzinga.com/news/24/04/38373389/tesla-ceo-elon-musk-takes-swipe-at-waymo-says-cybertruck-might-be-needed-for-robotaxis-in-san-franci">vandalism incidents</a> and regulatory hurdles. He has even suggested that the <a href="https://www.benzinga.com/news/24/04/38396288/teslas-robotaxi-to-be-called-cybercab-elon-musk-says-self-driving-fleet-will-be-like-combination-of">Tesla Cybertruck</a> might be necessary for robotaxis in San Francisco.
Analysts have also been weighing in on Tesla&#8217;s next-generation vehicle future, with some seeing the company as a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38411281/8-tesla-analysts-size-up-next-gen-vehicles-fsd-ai-and-more-potential-to-be-a-transf">transformational technology company</a> that could deliver outsized returns.
Goldman Sachs analysts have recognized Tesla as a leader in the autonomy and Advanced Driver-Assistance Systems (ADAS) landscape, projecting <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38314733/teslas-autonomous-driving-efforts-win-praise-from-goldman-sachs-wall-street-firm-pr">significant long-term growth</a> from its robotaxi services.
Read Next: <a href="https://www.benzinga.com/news/24/04/38285714/no-more-inventory-discounts-on-tesla-cars-as-ceo-elon-musk-says-sales-system-has-turned-complex-and?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">No More Inventory Discounts On Tesla Cars As CEO Elon Musk Says Sales System Has Turned &#8216;Complex And Inefficient&#8217;</a>
Image Via Shutterstock 
<div style="font-family: 'Lato', sans-serif">
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by 
 Benzinga Neuro, Edited by 
 
 <a href="None" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none"> 
 Kaustubh Bagalkote</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the 
 extensive Benzinga Ecosystem, including native data, APIs, and more to 
 create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/topic/kaustubh-bagalkote" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>

News

Tech

TSLA

XPEV

Tesla Is betting Big On Robotaxi, But This Rival Thinks Elon Musk's Vision Could Be 'More Than 5 Years Away'

Needham analyst Mike Cikos reiterates MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Buy and maintains $465 price target.

Price Target

Reiteration

Analyst Ratings

Needham Reiterates Buy on MongoDB, Maintains $465 Price Target

<ul>
<li>Leverage ratio of 4.5%, in line with previous quarter</li>
<li>Provision for credit losses of &euro; 439 million, down 10% from &euro; 488 million in fourth quarter of 2023; full-year guidance reaffirmed at higher end of range of 25-30 basis points of average loans</li>
</ul>

Earnings

General

Deutsche Bank Reports Q1 Common Equity Tier 1 Capital Ratio Of 13.4% After Deductions For Shareholder Distributions And Business-driven Growth In Risk Weighted Assets

Deutsche Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>) reported quarterly earnings of €0.69 per share which beat the analyst consensus estimate of €0.62 by 11.29 percent. This is a 13.11 percent increase over earnings of €0.61 per share from the same period last year. The company reported quarterly sales of €7.779 billion which beat the analyst consensus estimate of €7.711 billion by 0.89 percent. This is a 1.29 percent increase over sales of €7.680 billion the same period last year.

Earnings Beats

Deutsche Bank Q1 2024 GAAP EPS €0.69 Beats €0.62 Estimate, Sales €7.779B Beat €7.711B Estimate

Bernstein analyst Daniel Roeska initiates coverage on General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) with a Outperform rating and announces Price Target of $55.

Initiation

Bernstein Initiates Coverage On General Motors with Outperform Rating, Announces Price Target of $55

Wedbush analyst Richard Anderson downgrades First Industrial Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FR#NYSE">FR</a>) from Outperform to Neutral and lowers the price target from $59 to $49.

Downgrades

Wedbush Downgrades First Industrial Realty to Neutral, Lowers Price Target to $49

Truist Securities analyst Miller Jump downgrades HashiCorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) from Buy to Hold and raises the price target from $27 to $35.

Truist Securities Downgrades HashiCorp to Hold, Raises Price Target to $35

Elon Musk&nbsp;reacted to a user&#8217;s jest about the whereabouts of a former&nbsp;OpenAI chief scientist&nbsp;Ilya Sutskever, after Greg Brockman shared a photo with Sam Altman and&nbsp;Nvidia&nbsp;CEO&nbsp;Jensen Huang. 
What Happened: On Wednesday, Brockman, the president of ChatGPT&#8217;s parent company, took to X, formerly Twitter, and <a href="https://www.benzinga.com/news/24/04/38422652/jensen-huang-hand-delivers-nvidias-first-dgx-h200-gpu-to-openais-sam-altman-to-advance-ai-computing">shared the photo</a> saying, &#8220;First NVIDIA DGX H200 in the world, hand-delivered to OpenAI and dedicated by Jensen &#8216;to advance AI, computing, and humanity.'&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">First <a href="https://twitter.com/nvidia?ref_src=twsrc%5Etfw">@NVIDIA</a> DGX H200 in the world, hand-delivered to OpenAI and dedicated by Jensen &quot;to advance AI, computing, and humanity&quot;: <a href="https://t.co/rEJu7OTNGT">pic.twitter.com/rEJu7OTNGT</a>
&mdash; Greg Brockman (@gdb) <a href="https://twitter.com/gdb/status/1783234941842518414?ref_src=twsrc%5Etfw">April 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Following this, an X user, humorously commented,&nbsp;&#8220;Tell the truth. Is Ilya&nbsp;in the box?,&#8221; to which Tesla and SpaceX CEO&nbsp;Elon Musk responded&nbsp;with a face with tears&nbsp;of joy emoji.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/04/38400945/metas-massive-1b-bet-on-nvidia-h100-gpu-cluster-will-dwarf-every-other-companys-target-but-zuckerber?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Meta&#8217;s Massive $1B Bet On Nvidia H100 GPU Cluster Will Dwarf Every Other Company&#8217;s Target, But Zuckerberg Reveals Original Goal Was This, Not AI</a>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f602;
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1783262978193948851?ref_src=twsrc%5Etfw">April 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The <a href="https://www.benzinga.com/news/24/03/37809836/nvidia-reveals-blackwell-gpu-highlights-partnerships-with-top-companies-at-gtc-the-whole-industry-is">DGX H2000 is being hailed</a> as the most potent GPU globally. The H200 GPU succeeds the highly acclaimed H100 GPU, boasting 1.8 times the memory capacity and 1.4 times the bandwidth of its predecessor.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: The mention of&nbsp;Sutskever, OpenAI&#8217;s chief scientist, in the user&#8217;s comment has sparked renewed interest in <a href="https://www.benzinga.com/news/24/03/37814793/sam-altman-laughs-off-speculation-about-openais-ilya-sutskevers-whereabouts-i-really-hope-we-work-to">Sutskever&#8217;s mysterious absence</a>. Sutskever has been missing from the public eye since his <a href="https://www.benzinga.com/23/11/35861681/sam-altman-and-greg-brockman-shocked-and-saddened-after-removal-from-openai-over-google-meet">controversial &#8220;palace coup&#8221; in November</a>. 
His absence has been a subject of speculation, with even Sam Altman, OpenAI&#8217;s CEO, addressing the issue in a podcast. &#8220;I love Ilya. I have tremendous respect for Ilya. I really hope we work together for certainly the rest of my career,&#8221; the OpenAI CEO said in a conversation with Lex Fridman. 
Last year, following OpenAI employees&#8217; <a href="http://benzinga.com/news/23/11/35871393/openais-internal-strife-cto-coo-and-other-employees-unite-in-support-of-sam-altman" target="_blank" rel="noreferrer noopener">open rebellion</a> against the sudden firing of Altman and Brockman, Sutskever said that he would try to reunite the company. &#8220;I deeply regret my participation in the board's actions. I never intended to harm OpenAI,&#8221; he said at the time. 
Helen Toner, another board member who was part of Sutskever&#8217;s bid to remove Altman <a href="https://www.benzinga.com/news/23/11/35912540/sam-altman-tried-to-push-out-another-board-member-before-losing-and-getting-ousted-himself-report">left ChatGPT-parent</a> but Sutskever is still a part of it.
Check out more of Benzinga's Future Of Consumer Tech by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:&nbsp;<a href="https://www.benzinga.com/news/24/04/38357333/elon-musk-reacts-to-tucker-carlson-saying-theres-ton-of-evidence-that-aliens-live-among-us-with-6000?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla CEO Elon Musk Says He Feels &#8216;Like A Wince&#8217; When Saying &#8216;GPU&#8217; As He Boasts Rapid Progress With AI Compute: &#8216;Need A New Word&#8217;</a>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photos courtesy: Shutterstock

Elon Musk Laughs As X User Quip On Nvidia CEO Jensen Huang's Picture With Sam Altman And Greg Brockman: 'Is Ilya In The Box?'

Retail pharmacy giant&nbsp;Walgreens Boots Alliance Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) is bolstering its specialty pharmacy services, aiming&nbsp;to enhance patient outcomes and value for stakeholders.
The company unveiled Walgreens Specialty Pharmacy, an encompassing initiative to cater to patients with complex, chronic conditions while fostering profitable partnerships.
Read Next:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/large-cap/24/03/37967312/walgreens-challenges-nearly-1b-arbitration-award-over-alleged-breach-of-covid-19-test-business-con" rel="noreferrer noopener">Walgreens Challenges Nearly $1B Arbitration Award Over Alleged Breach of COVID-19 Test Business&nbsp;Contract</a>
Walgreens Specialty Pharmacy introduces a comprehensive suite of services, including gene and cell therapy solutions, marking a significant advancement in the company&#8217;s healthcare offerings.
Anchored by an 18,000-square-foot Innovation Center in Pittsburgh, Pennsylvania, the initiative focuses on managing therapy complexities and ensuring patient success.
Under the expanded business, Walgreens will operate four central specialty pharmacies, each with national accreditations and expertise in dispensing intricate medications.
Additionally, the company&#8217;s expansive network comprises nearly 300 community-based specialty&nbsp;pharmacies,&nbsp;strategically positioned for swift medication access and tailored patient services.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/03/37981845/walgreens-boots-alliance-cuts-higher-end-of-2024-profit-outlook-takes-5-8b-impairment-charge-relate" rel="noreferrer noopener">Walgreens Boots Alliance Cuts Higher End Of 2024 Profit Outlook, Takes $5.8B Impairment Charge Related To VillageMD&nbsp;Business</a>
With over 1,500 specialty-trained pharmacists and 5,000 patient advocacy support members, Walgreens Specialty Pharmacy&nbsp;is primed&nbsp;to address the burgeoning demand for specialized care.
Specialty medications constitute a significant portion of the U.S. prescription drug market, driving the need for tailored solutions.
Walgreens Specialty Pharmacy aims to meet this demand by streamlining care coordination across stakeholders, thereby enhancing patient access and driving cost efficiencies.
Effective August 1, 2024, AllianceRx Walgreens Pharmacy will transition to Walgreens Specialty Pharmacy, offering enhanced resources and clinical support to patients.
Walgreens&nbsp;stock lost over 48% in the last 12 months. Investors can gain exposure to the stock via&nbsp;Invesco High Yield Equity Dividend Achievers ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEY#NASDAQ">PEY</a>) and&nbsp;Invesco Dow Jones Industrial Average Dividend ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DJD#NYSE">DJD</a>).
Price Action: WBA shares are trading higher by 0.79% at $17.94 in premarket at last check Thursday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Wikimedia Commons

Equities

Walgreens Expands Specialty Pharmacy Business To Include Gene and Cell Services: Details

HSBC analyst Parash Jain upgrades United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) from Hold to Buy and raises the price target from $150 to $170.

Upgrades

HSBC Upgrades United Parcel Service to Buy, Raises Price Target to $170

Keybanc analyst Kenneth Zener upgrades Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) from Sector Weight to Overweight and announces $400 price target.

Keybanc Upgrades Sherwin-Williams to Overweight, Announces $400 Price Target

PureTech Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTC#NASDAQ">PRTC</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.93) by 74.19 percent. The company reported $3.330 million in sales this quarter. This is a 78.68 percent decrease over sales of $15.618 million the same period last year.

PRTC

PureTech Health FY 2023 GAAP EPS $(0.24) Beats $(0.93) Estimate, Sales $3.330M Down From $15.618M YoY

The CHIPS and Science Act grants of $6.1 billion will support Micron&#39;s plans to invest approximately $50 billion in gross capex for U.S. domestic leading-edge memory manufacturing through 2030. These grants and additional state and local incentives will support the construction of one leading-edge memory manufacturing fab to be co-located with the company&#39;s existing leading-edge R&amp;D facility in Boise, Idaho and the construction of two leading-edge memory fabs in Clay, New York.

Government

Large Cap

Micron Technology And The Biden-Harris Administration Have Signed A Non-binding Preliminary Memorandum Of Terms For $6.1B In Funding Under The CHIPS And Science Act To Support Planned Memory Manufacturing In Idaho And New York

Full-year 2024 revenues are expected to increase&nbsp;1.5%&nbsp;to&nbsp;3.5%&nbsp;on a reported basis and increase&nbsp;1%&nbsp;to&nbsp;3%&nbsp;organically, after excluding the expected impacts of acquisitions, divestitures and foreign currency movements.

Guidance

ALLE

Allegion Reaffirmed FY24 Outlook: Adjusted EPS At $7.00-$7.15 Vs. $7.07 Estimate, Revenue Growth At 1.5%-3.5%

Needham analyst Quinn Bolton upgrades Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) from Hold to Buy and announces $150 price target.

SLAB

Needham Upgrades Silicon Laboratories to Buy, Announces $150 Price Target

. This will enable TCO to expand Tengiz crude oil production by an incremental 12 million tons per annum (260,000 barrels a day)

Commodities

Markets

Chevron announced that its 50% owned affiliate Tengizchevroil has commenced operations at its Wellhead Pressure Management Project at the Tengiz oil field in Kazakhstan, The final phase of TCO's expansion project, is on track to conclude in 1H 2025

Needham analyst Ami Fadia reiterates Biogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) with a Buy and maintains $294 price target.

BIIB

Needham Reiterates Buy on Biogen, Maintains $294 Price Target

Allegion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLE#NYSE">ALLE</a>) reported quarterly earnings of $1.55 per share which beat the analyst consensus estimate of $1.45 by 6.9 percent. The company reported quarterly sales of $893.900 million which beat the analyst consensus estimate of $884.249 million by 1.09 percent. This is a 3.15 percent decrease over sales of $923.000 million the same period last year.

Allegion Q1 2024 Adj EPS $1.55 Beats $1.45 Estimate, Sales $893.900M Beat $884.249M Estimate

Keefe, Bruyette &amp; Woods analyst Catherine Mealor upgrades Trustmark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMK#NASDAQ">TRMK</a>) from Market Perform to Outperform and raises the price target from $30 to $36.

TRMK

Keefe, Bruyette & Woods Upgrades Trustmark to Outperform, Raises Price Target to $36

Mark Zuckerberg, the CEO of Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), has seemingly <a href="https://www.benzinga.com/general/gaming/24/02/37305770/mark-zuckerberg-on-a-mission-to-outdo-apple-vision-pro-meta-ceo-reportedly-eyes-south-korean-colla">taken a dig</a> at Apple Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) Vision Pro.
What Happened: Zuckerberg expressed his skepticism about the mainstream success of augmented reality (AR) glasses, particularly those without &#8220;full holographic displays," in a subtle jab at Apple Vision Pro during Meta&#8217;s <a href="https://www.benzinga.com/news/earnings/24/04/38416273/meta-platforms-q1-earnings-highlights-facebook-owner-beats-estimates-but-guidance-higher-costs-ding">first-quarter earnings call</a>.
&#8220;Now, it seems pretty clear that there&#8217;s also a meaningful market for fashionable AI glasses without a display."
Meta&#8217;s latest version of Ray-Ban smart glass, <a href="https://www.benzinga.com/general/entertainment/23/09/34964097/watch-mark-zuckerberg-unveils-metas-ai-smart-glasses-that-can-decode-anything-youre-looking">launched in September</a>, starts at $299 and comes with Meta AI, a camera, call-making capabilities, and built-in speakers.
Zuckerberg also emphasized the potential of these glasses as a &#8220;pretty meaningful and growing platform sooner than then I would have expected so.&#8221;
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Despite Meta&#8217;s Quest virtual reality headset competing with Apple&#8217;s Vision Pro, Zuckerberg has previously stated that he does not envision a future where people walk around with virtual reality headsets.
See Also: <a href="https://www.benzinga.com/news/24/04/38422652/jensen-huang-hand-delivers-nvidias-first-dgx-h200-gpu-to-openais-sam-altman-to-advance-ai-computing">Jensen Huang Hand-Delivers Nvidia&#8217;s First DGX H200 GPU To OpenAI&#8217;s Sam Altman To &#8216;Advance AI, Computing, And Humanity&#8217;</a>
Why It Matters: This isn&#8217;t the first time Zuckerberg has taken a swipe at the Apple Vision Pro. In February, he <a href="https://www.benzinga.com/general/entertainment/24/02/37116135/mark-zuckerberg-finally-tries-apples-vision-pro-and-says-metas-quest-3-is-the-better-produc">posted a video</a> reviewing Apple&#8217;s competing device, stating that the Quest not only had better value but was also &#8220;the better product period.&#8221;
This was echoed by Meta&#8217;s CTO, Andrew Bosworth, who <a href="https://www.benzinga.com/general/entertainment/24/02/37175237/metas-tech-chief-echoes-zuckerbergs-review-of-apple-vision-pro-says-way-too-much-weight-dis">highlighted several issues</a> with the Vision Pro, dismissing reports about its technological superiority.
In March, Zuckerberg also <a href="https://www.benzinga.com/news/24/03/37616210/mark-zuckerberg-refutes-analysts-claim-quest-not-basically-just-the-same-as-apples-vision-pro">refuted the notion</a> that the Vision Pro was comparable to Meta&#8217;s Quest lineup.
Meanwhile, Apple&#8217;s Vision Pro has been facing challenges, with reports of <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38397921/apple-in-trouble-tim-cook-reportedly-cuts-vision-pro-shipment-forecasts-by-up-to-50">a significant drop in demand</a> leading to a cut in shipment forecasts by up to 50%.
Price Action:&nbsp;Meta stock closed 0.52% lower at $493.50 on Wednesday, according to&nbsp;<a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:&nbsp;<a href="https://www.benzinga.com/news/24/04/38420928/meta-ceo-mark-zuckerberg-more-than-50-of-the-content-people-see-on-instagram-is-now-ai-recommended" target="_blank" rel="noreferrer noopener">Meta CEO Mark Zuckerberg: ‘More Than 50% Of The Content People See On Instagram Is Now AI Recommended'</a>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Ray-Ban